SCHEMBL17038482

SCHEMBL17038482

CCCCSc1ccccc1SC

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.53
TLR8 Q9NR97 1/20 0.46
HPGD P15428 1/20 0.42
SOAT1 P35610 2/20 0.41
S100A4 P26447 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
EPHX2 P34913 1/20 0.38
HTT P42858 1/20 0.37
CHRM2 P08172 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8672850 0.91 PTGS2 (0.59) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL9515947 0.81 PTGS2 (0.54) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL425178 0.79 TLR8 (0.54) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL15956232 0.79 PTGS2 (0.57) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL7264640 0.79 PTGS2 (0.53) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL10144166 0.78 ALDH1A1 (0.47) HPGDSOAT1S100A4NPC1RAB9A
SCHEMBL19002781 0.78 PTGS2 (0.51) PTGS2TLR8HPGDSOAT1S100A4
SCHEMBL6039974 0.78 HTR7 (0.59) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL28327301 0.78 PTGS2 (0.51) PTGS2TLR8SOAT1S100A4NPC1
SCHEMBL2974208 0.78 PTGS2 (0.51) PTGS2TLR8SOAT1S100A4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019025156-A1 SUBSTITUTED PYRROLIDINONES, SALTS THEREOF AND USE THEREOF AS HERBICIDAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2019-02-07 WO disclosed
US-9481645-B2 Composition, synthesis, and use of a new class of isonitriles DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2016-11-01 US disclosed
US-9481645-B2 Composition, synthesis, and use of a new class of isonitriles DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2016-11-01 US disclosed
US-20150239835-A1 COMPOSITION, SYNTHESIS, AND USE OF A NEW CLASS OF ISONITRILES DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2015-08-27 US disclosed
US-20150239835-A1 COMPOSITION, SYNTHESIS, AND USE OF A NEW CLASS OF ISONITRILES DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239835-A1 COMPOSITION, SYNTHESIS, AND USE OF A NEW CLASS OF ISONITRILES CYP3A4, UGT1A4, INTS9 PTGS2 3479/4885TLR8 4757/4885HPGD 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.